Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2412-2419

  Mendoza, Ramon ^a,b   Dusty Miller, A ^a   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Microbiology and Quality Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; PROTEIN THTR1; PROTEIN THTR2; RNA; THIAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CAT; CELL GROWTH; CELL LINE; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; FELINE LEUKEMIA VIRUS A; FELINE LEUKEMIA VIRUS A INFECTION; FIBROBLAST; GROWTH INHIBITION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THIAMINE UPTAKE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CATS; CELL LINE; CELL PROLIFERATION; LEUKEMIA VIRUS, FELINE; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; RETROVIRIDAE INFECTIONS; THIAMINE; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84874681799     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03203-12     Document Type: Article

References (45)

1. Levy J, Crawford C, Hartmann K, Hofmann-Lehmann R, Little S, Sundahl E, Thayer V. 2008. 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J. Feline Med. Surg. 10: 300-316.
2. Hartmann K. 2011. Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Vet. Immunol. Immunopathol. 143:190-201.
3. Willett BJ, Hosie MJ. 2013. Feline leukaemia virus: half a century since its discovery. Vet. J. 195:16-23.
4. Rohn JL, Overbaugh J. 1999. Feline leukemia virus and feline immunodeficiency virus, p 379-408. In Ahmed R, Chen I (ed), Persistent viral infections. John Wiley & Sons, Hoboken, NJ.
5. Overbaugh J, Riedel N, Hoover EA, Mullins JI. 1988. Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature 332:731-734.
6. Boomer S, Gasper P, Whalen LR, Overbaugh J. 1994. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A. Virology 204:805-810.
7. Rohn JL, Moser MS, Gwynn SR, Baldwin DN, Overbaugh J. 1998. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant. J. Virol. 72:2686-2696.
8. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, Abkowitz JL. 2004. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118:757-766.
9. Mendoza R, Anderson MM, Overbaugh J. 2006. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J. Virol. 80:3378-3385.
10. Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. 1999. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat. Genet. 22: 309-312.
11. Dutta B, Huang W, Molero M, Kekuda R, Leibach FH, Devoe LD, Ganapathy V, Prasad PD. 1999. Cloning of the human thiamine transporter, a member of the folate transporter family. J. Biol. Chem. 274: 31925-31929.
12. Fleming JC, Tartaglini E, Steinkamp MP, Schorderet DF, Cohen N, Neufeld EJ. 1999. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat. Genet. 22:305-308.
13. Eudy JD, Spiegelstein O, Barber RC, Wlodarczyk BJ, Talbot J, Finnell RH. 2000. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol. Genet. Metab. 71:581-590.
14. Rajgopal A, Edmondnson A, Goldman ID, Zhao R. 2001. SLC19A3 encodes a second thiamine transporter ThTr2. Biochim. Biophys. Acta 1537:175-178.
15. Porter FS, Rogers LE, Sidbury JB. 1969. Thiamine-responsive megaloblastic anemia. J. Pediatr. 74:494-504.
16. Stagg AR, Fleming JC, Baker MA, Sakamoto M, Cohen N, Neufeld EJ. 1999. Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. J. Clin. Invest. 103:723-729.
17. Zeng WQ, Al-Yamani E, Acierno JS, Jr, Slaugenhaupt S, Gillis T, MacDonald ME, Ozand PT, Gusella JF. 2005. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am. J. Hum. Genet. 77:16-26.
18. Debs R, Depienne C, Rastetter A, Bellanger A, Degos B, Galanaud D, Keren B, Lyon-Caen O, Brice A, Sedel F. 2010. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. Arch. Neurol. 67:126-130.
19. Miller AD, Rosman GJ. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990.
20. Leutenegger CM, Klein D, Hofmann-Lehmann R, Mislin C, Hummel U, Boni J, Boretti F, Guenzburg WH, Lutz H. 1999. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J. Virol. Methods 78:105-116.
21. Lander MR, Chattopadhyay SK. 1984. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focusforming viruses. J. Virol. 52:695-698.
22. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
23. Anderson MM, Lauring AS, Robertson S, Dirks C, Overbaugh J. 2001. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. J. Virol. 75:10563-10572.
24. Moser M, Burns CC, Boomer S, Overbaugh J. 1998. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors. Virology 242:366-377.
25. Sugai J, Eiden M, Anderson MM, Van Hoeven N, Meiering CD, Overbaugh J. 2001. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J. Virol. 75:6841-6849.
26. Donahue PR, Hoover EA, Beltz GA, Riedel N, Hirsch VM, Overbaugh J, Mullins JI. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62: 722-731.
27. Boomer S, Eiden M, Burns CC, Overbaugh J. 1997. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 71: 8116-8123.
28. Rudra-Ganguly N, Ghosh AK, Roy-Burman P. 1998. Retrovirus receptor PiT-1 of the Felis catus. Biochim. Biophys. Acta 1443:407-413.
29. Tailor CS, Willett BJ, Kabat D. 1999. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J. Virol. 73:6500-6505.
30. Quigley JG, Burns CC, Anderson MM, Lynch ED, Sabo KM, Overbaugh J, Abkowitz JL. 2000. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95:1093-1099.
31. Shalev Z, Duffy SP, Adema KW, Prasad R, Hussain N, Willett BJ, Tailor CS. 2009. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J. Virol. 83: 6706-6716.
32. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
33. Ferguson PL, Flintoff WF. 1999. Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J. Biol. Chem. 274:16269-16278.
34. Fleming JC, Steinkamp MP, Kawatsuji R, Tartaglini E, Pinkus JL, Pinkus GS, Fleming MD, Neufeld EJ. 2001. Characterization of a murine high-affinity thiamine transporter, Slc19a2. Mol. Genet. Metab. 74:273-280.
35. Oishi K, Hirai T, Gelb BD, Diaz GA. 2001. Slc19a2: cloning and characterization of the murine thiamin transporter cDNA and genomic sequence, the orthologue of the human TRMA gene. Mol. Genet. Metab. 73:149-159.
36. Miyazawa T, Furuya T, Itagaki S, Tohya Y, Takahashi E, Mikami T. 1989. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108:131-135.
37. Snyder HW, Hardy WD, Zuckerman EE, Fleissner E. 1978. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature 275:656-658.
38. Crandell RA, Fabricant CG, Nelson-Rees WA. 1973. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
39. Baker H, Schor SM, Murphy BD, DeAngelis B, Feingold S, Frank O. 1986. Blood vitamin and choline concentrations in healthy domestic cats, dogs, and horses. Am. J. Vet. Res. 47:1468-1471.
40. Helfer-Hungerbuehler AK, Cattori V, Bachler B, Hartnack S, Riond B, Ossent P, Lutz H, Hofmann-Lehmann R. 2011. Quantification and molecular characterization of the feline leukemia virus A receptor. Infect. Genet. Evol. 11:1940-1950.
41. Meli ML, Cattori V, Martinez F, Lopez G, Vargas A, Simon MA, Zorrilla I, Munoz A, Palomares F, Lopez-Bao JV, Pastor J, Tandon R, Willi B, Hofmann-Lehmann R, Lutz H. 2009. Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One 4:e4744. doi:10.1371/journal.pone.0004744.
42. Brown MA, Cunningham MW, Roca AL, Troyer JL, Johnson WE, O'Brien SJ. 2008. Genetic characterization of feline leukemia virus from Florida panthers. Emerg. Infect. Dis. 14:252-259.
43. Alzahrani AS, Baitei E, Zou M, Shi Y. 2006. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Eur. J. Endocrinol. 155:787-792.
44. Pichler H, Zeitlhofer P, Dworzak MN, Diakos C, Haas OA, Kager L. 2012. Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations. Eur. J. Pediatr. 171:1711-1715.
45. Oishi K, Hofmann S, Diaz GA, Brown T, Manwani D, Ng L, Young R, Vlassara H, Ioannou YA, Forrest D, Gelb BD. 2002. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum. Mol. Genet. 11:2951-2960.